Patients in a hospital's emergency department are to be tested for blood-borne viruses like HIV. The pilot project at ...

Those include Sunlenca, which is approved for resistant HIV as a twice-yearly injection after an initial oral regimen, and ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

Fostemsavir plus optimized background therapy was associated with improvements in immune biomarkers among HTE patients with MDR HIV infection.

Kidney transplantation from donors with HIV appeared to be noninferior to donors without HIV in terms of safety for ...

Gilead and Merck & Co. have guided their once-weekly HIV combination therapy past another milestone, linking the cocktail to ...

The national HIV prevalence was 16. 3% among adults aged 15 years and older, translating to an estimated 7. 4 million adults ...

HIV is a virus. It may cause AIDS after you’ve been infected for several years and it’s weakened your immune system. HIV doesn’t affect everyone the same way. Some people notice signs soon ...

Two posters compared health care resource utilization (HCRU) and financial burdens of people living with HIV with a non-HIV ...

New data from the PURPOSE 2 trial continue to show the efficacy of lenacapavir in HIV prevention in individuals who have sex ...

Three absurdly cheap dividend stocks that are trading at modest multiples of their expected earnings today are Merck ( MRK -0 ...

Natal, alarming gaps between scientific advancements and community behaviour persist. This article explores the critical need ...